| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Liao,Ren-Qun | Chairman | 1.20% | |
| Wang,Feng-Zhen | Managing Director | 2.79% | |
| Chen,Xin-Zhi | Managing Director | 2.36% | |
| Cai,Zheng-Xiang | Managing Director | 0.23% | |
| Shi,Ren-Zheng | Managing Director | 0.06% | |
| Xiong,Zhao-Qi | Director | 1.12% | |
| Wu,Ming-Zhi | Director | 0.66% | |
| Qiu,Wen-Xiong | Director | 1.25% | |
| Vacancy | Director | ||
| Peng,Cong-Shun | Director | 0.14% | |
| Chen,Sheng-Ren | Director | 0.44% | |
| Qiu,Guo-Zhen | Director | 2.02% | |
| Lin,Ru-Yan | Director | 0.77% | |
| Lai,Hong-Rong | Director | 0.05% | |
| Wu,Zhi-Ren | Director | 1.30% | |
| Xiao,Qin-Hua | Supervisor | 0.23% | |
| Deng,Yong-Hui | Supervisor | 0.54% | |
| Huang,Yu-Sheng | Supervisor | 0.42% |
| 項目 | 2023 | 2022 | 2021 |
|---|---|---|---|
| Operating income | 4,383,114 | 5,155,950 | 6,028,277 |
| Operating cost | 3,383,564 | 3,830,634 | 4,260,358 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | 999,550 | 1,325,316 | 1,767,919 |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | 999,550 | 1,325,316 | 1,767,919 |
| Operating expenses | 913,478 | 902,676 | 937,929 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | 86,072 | 422,640 | 829,990 |
| Non-operating income and expenses | 261,478 | 338,259 | 294,144 |
| Net profit (loss) before tax | 347,550 | 760,899 | 1,124,134 |
| Income tax expense (benefits) | 139,435 | 249,922 | 291,338 |
| Net profit (loss) of ongoing business for the current period | 208,115 | 510,977 | 832,796 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | 208,115 | 510,977 | 832,796 |
| Other comprehensive profit (loss), net | -48,487 | 208,814 | -70,751 |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | 159,628 | 719,791 | 762,045 |
| Net profit (loss) attributable to owners of parent company | 183,907 | 364,168 | 653,595 |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | 24,208 | 146,809 | 179,201 |
| Comprehensive profit (loss) attributable to owners of parent company | 151,872 | 535,427 | 602,992 |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | 7,756 | 184,364 | 159,053 |
| Basic earnings per share (yuan) | 2 | 5 | 10 |
| 項目 | 2023 | 2022 | 2021 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | 749,726 | 614,749 | 768,561 |
| Net cash inflows (outflows) from investing activities | 19,400 | -152,239 | -329,304 |
| Net cash inflow (outflow) from financing activities | -491,222 | -493,152 | -534,594 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | -20,171 | 169,114 | -53,279 |
| Increase (decrease) in cash and cash equivalents in the current period | 257,733 | 138,472 | -148,616 |
| Beginning balance of cash and cash equivalents | 2,083,728 | 1,945,256 | 2,093,872 |
| Ending balance of cash and cash equivalents | 2,341,461 | 2,083,728 | 1,945,256 |
| 項目 | 2023 | 2022 | 2021 |
|---|---|---|---|
| Current asset | 5,016,447 | 5,461,942 | 5,392,447 |
| Non-current asset | 5,454,675 | 5,524,397 | 5,427,488 |
| Total asset | 10,471,122 | 10,986,339 | 10,819,935 |
| Current liability | 1,568,727 | 1,729,733 | 1,652,549 |
| Non-current liability | 797,142 | 894,458 | 999,020 |
| Total liability | 2,365,869 | 2,624,191 | 2,651,569 |
| share capital | 637,665 | 637,665 | 637,665 |
| Equity - secruity token | - | - | - |
| capital reserve | 81,349 | 81,349 | 81,349 |
| retained earning | 6,373,074 | 6,450,403 | 6,408,289 |
| Other equity | -98,300 | -72,435 | -215,032 |
| Treasury stock | - | - | - |
| Total equity attributable to owners of parent company | 6,993,788 | 7,096,982 | 6,912,271 |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | 1,111,465 | 1,265,166 | 1,256,095 |
| Total Equity | 8,105,253 | 8,362,148 | 8,168,366 |
| Share capital awaiting retirement (unit: share) | - | - | - |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
| Net asset value per share | 109 | 111 | 108 |
